1. Home
  2. TNGX vs SQFTP Comparison

TNGX vs SQFTP Comparison

Compare TNGX & SQFTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • SQFTP
  • Stock Information
  • Founded
  • TNGX 2014
  • SQFTP N/A
  • Country
  • TNGX United States
  • SQFTP United States
  • Employees
  • TNGX N/A
  • SQFTP 15
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • SQFTP Real Estate Investment Trusts
  • Sector
  • TNGX Health Care
  • SQFTP Real Estate
  • Exchange
  • TNGX Nasdaq
  • SQFTP Nasdaq
  • Market Cap
  • TNGX 735.0M
  • SQFTP N/A
  • IPO Year
  • TNGX N/A
  • SQFTP N/A
  • Fundamental
  • Price
  • TNGX $6.64
  • SQFTP $14.70
  • Analyst Decision
  • TNGX Strong Buy
  • SQFTP
  • Analyst Count
  • TNGX 8
  • SQFTP 0
  • Target Price
  • TNGX $15.14
  • SQFTP N/A
  • AVG Volume (30 Days)
  • TNGX 885.7K
  • SQFTP N/A
  • Earning Date
  • TNGX 11-06-2024
  • SQFTP N/A
  • Dividend Yield
  • TNGX N/A
  • SQFTP N/A
  • EPS Growth
  • TNGX N/A
  • SQFTP N/A
  • EPS
  • TNGX N/A
  • SQFTP N/A
  • Revenue
  • TNGX $42,509,000.00
  • SQFTP N/A
  • Revenue This Year
  • TNGX $18.15
  • SQFTP N/A
  • Revenue Next Year
  • TNGX N/A
  • SQFTP N/A
  • P/E Ratio
  • TNGX N/A
  • SQFTP N/A
  • Revenue Growth
  • TNGX 26.16
  • SQFTP N/A
  • 52 Week Low
  • TNGX $6.33
  • SQFTP N/A
  • 52 Week High
  • TNGX $13.01
  • SQFTP N/A
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.15
  • SQFTP 49.30
  • Support Level
  • TNGX $6.83
  • SQFTP $13.98
  • Resistance Level
  • TNGX $7.47
  • SQFTP $14.98
  • Average True Range (ATR)
  • TNGX 0.37
  • SQFTP 0.62
  • MACD
  • TNGX 0.11
  • SQFTP 0.04
  • Stochastic Oscillator
  • TNGX 27.31
  • SQFTP 69.44

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About SQFTP Presidio Property Trust Inc. 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock $0.01 par value per share

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: